Lincoln Pharmaceuticals Share Price

Lincoln Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceutical Products, Export Incentives, Job Work, Sale of services and Scrap for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 183.08 Crore, up .89 % from last quarter Total Income of Rs 181.47 Crore and up 13.50 % from last year same quarter Total Income of Rs 161.30 Crore. Company has reported net profit after tax of Rs 11.63 Crore in latest quarter.

The company’s top management includes Mr.Kishor M Shah, Mr.Mahendra G Patel, Mr.Ashish R Patel, Mr.Hashmukh I Patel, Mr.Munjal M Patel, Mr.Rajnikant G Patel, Mr.Nareshkumar Suthar, Mr.Saurin J Parikh, Ms.Seema Mehta, Mr.Darshit A Shah, Ms.Trusha K Shah. Company has J T Shah & Co. as its auditors. As on 31-03-2026, the company has a total of 2.00 Crore shares outstanding.

Lincoln Pharma Share Price Today is Rs. 636.10. On previous day, the Lincoln Pharma Share Price (NSE) closed at Rs. 633.3, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 49.78% of the stake in Lincoln Pharma shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Lincoln Pharma stocks was 5.2% as compared to 4.7% in Dec 2025 with increase of 0.5%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 1.08% as compared to 0.01% in Dec 2025 with increase of 1.07%. Out of the total DII holdings in Lincoln Pharma shares 0.0% was held by mutual funds. The rest including public held is 43.94%. Lincoln Pharma stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Lincoln Pharma Dividend: Ever since 1995, Lincoln Pharma dividends has been paid out around 27 times. As on 12 Jun, 2026, 03:53 PM IST, The overall dividend yield for Lincoln Pharma stands at 0.0%. The last dividend paid was on September 12, 2025 (Rs. 1.8). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 43.88.

Lincoln Pharma Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 183.08 Cr. of sales and 0.89% of quarterly net profit, there have been multiple ups and downs in the Lincoln Pharma stock prices in the past few weeks. For example, Lincoln Pharma stock price on 4th of June 2026 was around Rs. 619.55. Lincoln Pharma share price now stands at an average of Rs. 636.10. Judging by last week's performance, stock is in up trend.

Lincoln Pharma has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Lincoln Pharma share.

Historical Prices and Performance:
Lincoln Pharma, incorporated in 1995 is a Small Cap company (with a market cap of Rs. 1261.17) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Lincoln Pharma stock was 11.6%, 12.25%, 15.73%, 14.5% and 16.02% respectively.
The Lincoln Pharma share gave a 3 year return of 65.07% as compared to Nifty 50 which gave a return of 24.77%.
Lincoln Pharma announced 18.0% final dividend on September 12, 2025.

Key Metrics:
PE Ratio of Lincoln Pharma is 14.43
Prices/Sales Ratio of Lincoln Pharma is 1.68
Price/Book Ratio of Lincoln Pharma is 1.67

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Lincoln Pharma, major competitors and peers include NGL Fine Chem, Ind-Swift Labs, Jagsonpal Pharm and Syncom Form. As of Dec 2025, the dividend yield of Lincoln Pharma stands at 0.0% while NGL Fine Chem, Ind-Swift Labs, Jagsonpal Pharm and Syncom Form stand at 0.06%, 0.0%, 1.91% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 14.43 and 1.67 respectively.

Leadership of Lincoln Pharma :
Darshit A Shah is Chief Financial Officer
Trusha K Shah is Co. Secretary & Compl. Officer
Kishor M Shah is Non Executive Chairman
Mahendra G Patel is Managing Director
Hashmukh I Patel is Whole Time Director
Munjal M Patel is Whole Time Director
Ashish R Patel is Whole Time Director
Rajnikant G Patel is Non Executive Director
Nareshkumar Suthar is Independent Director
Saurin J Parikh is Independent Director
Seema Mehta is Independent Director